Insulin Glargine And Lixisenatide

2 indexed presentations.

Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review NDC-level listings, compare package configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Drug Directory A-Z | Drug names: I | Drug Search | Request a Quote Review

Generic details

Review dosage forms, strengths, package variations, and manufacturer identifiers associated with Insulin Glargine And Lixisenatide.

  • Indexed presentation count: 2 indexed presentations.
  • Common dosage forms: Injection.

Common presentations

Compare presentation differences here, then open the table rows below for NDC-level confirmation.

  • Strength variation: 100 U / mL; 33 ug / mL.
  • Package variation: 1 Syringe and 5 Syringe.
  • Manufacturer information is shown for product identification only.

Official references

Use official label-search references for this generic family when your team needs supplemental labeling context.

Showing page 1 of 1
Soliqua 100/33 - Insulin glargine and lixisenatide 100 U / mL; 33 ug / mL Injection 3 mL00024-5761-01100 U / mL; 33 ug / mLInjection1 Syringe
Soliqua 100/33 - Insulin glargine and lixisenatide 100 U / mL; 33 ug / mL Injection 3 mL00024-5761-05100 U / mL; 33 ug / mLInjection5 Syringe

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.